COPD Teaching 1760
SN instructed that Breo Ellipta is used regularly as a long term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Instructed that common side effects include, Headache, dry/irritated throat, hoarseness, runny nose, and coughing may occur as your body adjusts to the medication.
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
COPD Teaching 833Instructed on some signs/symptoms of respiratory infection, such as: cough (may be productive) and malaise, among others.COPD Teaching 830Instructed on some signs/symptoms of respiratory infection, such as: sputum (green, yellow or rust-colored), among others.COPD Teaching 1401The patient was instructed in COPD: Chronic Obstructive Pulmonary Disease or Chronic Obstructive Lung Disease the importance of avoiding bronchopulmonary irritants such as cigarettes smoking, industrial air pollutants, d...COPD Teaching 827Instructed on the importance of reporting changes in sputum characteristics or cough pattern.